ロード中...
Irinotecan plus carboplatin for patients with carcinoma of unknown primary site
Carcinoma of unknown primary site (CUP) is rarely encountered in clinical practice and optimal chemotherapy has not yet been established. This phase II study was conducted to evaluate the efficacy and toxicity of combined irinotecan+carboplatin therapy in chemotherapy-naive patients with CUP. Irinot...
保存先:
| 主要な著者: | , , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group
2009
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2634680/ https://ncbi.nlm.nih.gov/pubmed/19088717 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6604829 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|